Kai Wang, Yun-fan Li, Qi Lv, Xi-ming Li, Yue Dai, & Zhi-feng Wei. (2018). Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation. Frontiers Media S.A..
Chicago Style (17th ed.) CitationKai Wang, Yun-fan Li, Qi Lv, Xi-ming Li, Yue Dai, and Zhi-feng Wei. Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice Through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation. Frontiers Media S.A., 2018.
MLA (9th ed.) CitationKai Wang, et al. Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice Through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation. Frontiers Media S.A., 2018.